Triple Gate Capital Founder Raises Concerns Over AbbVie's Reproxalap Claims in FDA Submission
2025-11-07
PubComNonGov2025-11-07
Carter Struck
WASHINGTON, Nov. 7 -- Norbert Gottesman, founder of Triple Gate Capital LP, Woodmere, New York, has submitted a public comment letter to the Food and Drug Administration raising serious concerns regar . . .
TARGETED NEWS SERVICE (founded 2004) features non-partisan 'edited journalism' news briefs and information for news organizations, public policy groups and individuals; as well as 'gathered' public policy information, including news releases, reports, speeches. For more information contact MYRON STRUCK, editor, editor@targetednews.com, Springfield, Virginia; 703/304-1897; https://targetednews.com
WASHINGTON, Nov. 7 -- Norbert Gottesman, founder of Triple Gate Capital LP, Woodmere, New York, has submitted a public comment letter to the Food and Drug Administration raising serious concerns regar . . .
TARGETED NEWS SERVICE (founded 2004) features non-partisan 'edited journalism' news briefs and information for news organizations, public policy groups and individuals; as well as 'gathered' public policy information, including news releases, reports, speeches. For more information contact MYRON STRUCK, editor, editor@targetednews.com, Springfield, Virginia; 703/304-1897; https://targetednews.com
Copyright © Targeted News Service, 2025